SuspendedPhase 3Phase 4ACTRN12611000297921
A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients
Sponsor
Department of Renal Medicine
Enrollment
380 participants
Start Date
Apr 1, 2011
Study Type
Interventional
Conditions
Summary
not recruiting
Eligibility
Sex: Both males and femalesMin Age: 18 YearssMax Age: 80 Yearss
Inclusion Criteria2
- Patients on peritoneal dialysis.( Incident and prevalent)
- Able to give informed consent
Exclusion Criteria4
- PD patients who had exit site infection, peritonitis, or tunnel infection within the last 4 weeks
- Known hypersensitivity to, or intolerance of, honey or mupirocin.
- On long term antibiotics for any reason.
- Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Once daly application of Topical Medihoney (gauze pad) approximately10 mg ( size of a pea) at Peritoneal dialysis catheter exit site once daily (the medihoney dressing will be changed daily ) compared
Once daly application of Topical Medihoney (gauze pad) approximately10 mg ( size of a pea) at Peritoneal dialysis catheter exit site once daily (the medihoney dressing will be changed daily ) compared topical application of small amount Mupirocin using cotton bud to Peritoneal dialysis catheter exit site once daily ( 12 months )
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000297921